1. Home
  2. EPSN vs ALXO Comparison

EPSN vs ALXO Comparison

Compare EPSN & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

N/A

Current Price

$5.16

Market Cap

187.2M

Sector

Energy

ML Signal

N/A

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

N/A

Current Price

$1.27

Market Cap

172.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EPSN
ALXO
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.2M
172.8M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
EPSN
ALXO
Price
$5.16
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $4.60
AVG Volume (30 Days)
56.9K
★ 1.4M
Earning Date
11-20-2026
11-20-2026
Dividend Yield
★ 4.84%
N/A
EPS Growth
N/A
★ 26.36
EPS
★ 0.26
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.88
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.86
52 Week High
$6.65
$2.66

Technical Indicators

Market Signals
Indicator
EPSN
ALXO
Relative Strength Index (RSI) 26.68 50.26
Support Level N/A $1.03
Resistance Level $6.01 $1.34
Average True Range (ATR) 0.24 0.14
MACD -0.14 0.03
Stochastic Oscillator 1.84 60.26

Price Performance

Historical Comparison
EPSN
ALXO

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: